BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 32014569)

  • 1. Development and Validation of a Laboratory Risk Score (LabScore) to Predict Outcomes after Resection for Intrahepatic Cholangiocarcinoma.
    Tsilimigras DI; Mehta R; Aldrighetti L; Poultsides GA; Maithel SK; Martel G; Shen F; Koerkamp BG; Endo I; Pawlik TM;
    J Am Coll Surg; 2020 Apr; 230(4):381-391.e2. PubMed ID: 32014569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative Risk Score and Prediction of Long-Term Outcomes after Hepatectomy for Intrahepatic Cholangiocarcinoma.
    Sasaki K; Margonis GA; Andreatos N; Bagante F; Weiss M; Barbon C; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Aucejo FN; Pawlik TM
    J Am Coll Surg; 2018 Apr; 226(4):393-403. PubMed ID: 29274841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel online prognostic tool to predict long-term survival after liver resection for intrahepatic cholangiocarcinoma: The "metro-ticket" paradigm.
    Sahara K; Tsilimigras DI; Mehta R; Bagante F; Guglielmi A; Aldrighetti L; Alexandrescu S; Marques HP; Shen F; Koerkamp BG; Endo I; Pawlik TM
    J Surg Oncol; 2019 Aug; 120(2):223-230. PubMed ID: 31004365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.
    Wang JJ; Li H; Li JX; Xu L; Wu H; Zeng Y
    World J Gastroenterol; 2020 Apr; 26(13):1501-1512. PubMed ID: 32308350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi-institutional analysis of 706 patients.
    Tsilimigras DI; Hyer JM; Moris D; Sahara K; Bagante F; Guglielmi A; Aldrighetti L; Alexandrescu S; Marques HP; Shen F; Koerkamp BG; Endo I; Pawlik TM;
    J Surg Oncol; 2019 Aug; 120(2):206-213. PubMed ID: 31025380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma.
    Buettner S; Spolverato G; Kimbrough CW; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Weiss M; Bauer TW; Shen F; Poultsides GA; Marsh JW; IJzermans JNM; Koerkamp BG; Pawlik TM
    Surgery; 2018 Sep; 164(3):411-418. PubMed ID: 29903509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional Probability of Long-term Survival After Liver Resection for Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 535 Patients.
    Spolverato G; Kim Y; Ejaz A; Alexandrescu S; Marques H; Aldrighetti L; Gamblin TC; Pulitano C; Bauer TW; Shen F; Sandroussi C; Poultsides G; Maithel SK; Pawlik TM
    JAMA Surg; 2015 Jun; 150(6):538-45. PubMed ID: 25831462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative prognostic nutritional index predicts survival of patients with intrahepatic cholangiocarcinoma after curative resection.
    Akgül Ö; Bagante F; Olsen G; Cloyd JM; Weiss M; Merath K; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Pawlik TM
    J Surg Oncol; 2018 Sep; 118(3):422-430. PubMed ID: 30084163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multi-institutional International Analysis of Textbook Outcomes Among Patients Undergoing Curative-Intent Resection of Intrahepatic Cholangiocarcinoma.
    Merath K; Chen Q; Bagante F; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Weiss MJ; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Cloyd JM; Pawlik TM
    JAMA Surg; 2019 Jun; 154(6):e190571. PubMed ID: 31017645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Machine-Based Approach to Preoperatively Identify Patients with the Most and Least Benefit Associated with Resection for Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis of 1146 Patients.
    Tsilimigras DI; Mehta R; Moris D; Sahara K; Bagante F; Paredes AZ; Moro A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Endo I; Pawlik TM
    Ann Surg Oncol; 2020 Apr; 27(4):1110-1119. PubMed ID: 31728792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.
    Hyder O; Marques H; Pulitano C; Marsh JW; Alexandrescu S; Bauer TW; Gamblin TC; Sotiropoulos GC; Paul A; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Popescu I; Gigot JF; Mentha G; Feng S; Pawlik TM
    JAMA Surg; 2014 May; 149(5):432-8. PubMed ID: 24599477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches.
    Tsilimigras DI; Sahara K; Wu L; Moris D; Bagante F; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Moro A; Sasaki K; Aucejo F; Zhang XF; Matsuyama R; Endo I; Pawlik TM
    JAMA Surg; 2020 Sep; 155(9):823-831. PubMed ID: 32639548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection.
    Bagante F; Spolverato G; Merath K; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Endo I; Pawlik TM
    Surgery; 2019 Dec; 166(6):983-990. PubMed ID: 31326191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.
    Saito H; Noji T; Okamura K; Tsuchikawa T; Shichinohe T; Hirano S
    Surgery; 2016 Mar; 159(3):842-51. PubMed ID: 26683498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma.
    Bagante F; Spolverato G; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
    J Gastrointest Surg; 2017 Nov; 21(11):1888-1897. PubMed ID: 28840497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
    Nickkholgh A; Ghamarnejad O; Khajeh E; Tinoush P; Bruckner T; Kulu Y; Mieth M; Goeppert B; Roessler S; Weiss KH; Hoffmann K; Büchler MW; Mehrabi A
    BJS Open; 2019 Dec; 3(6):793-801. PubMed ID: 31832586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
    Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
    [No Abstract]   [Full Text] [Related]  

  • 18. Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy.
    Zhang XF; Bagante F; Chakedis J; Moris D; Beal EW; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
    J Gastrointest Surg; 2017 Nov; 21(11):1841-1850. PubMed ID: 28744741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Utility of the Glasgow Prognostic Score for the Long-Term Outcomes After Liver Resection for Intrahepatic Cholangiocarcinoma: A Multi-institutional Study.
    Sui K; Okabayashi T; Umeda Y; Oishi M; Kojima T; Sato D; Endo Y; Ota T; Hioki K; Inagaki M; Matsuda T; Hirai R; Kimura M; Yagi T; Fujiwara T
    World J Surg; 2021 Jan; 45(1):279-290. PubMed ID: 32989578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection.
    Lei Z; Xia Y; Si A; Wang K; Li J; Yan Z; Yang T; Wu D; Wan X; Zhou W; Liu J; Wang H; Cong W; Wu M; Pawlik TM; Lau WY; Shen F
    J Hepatol; 2018 Apr; 68(4):655-662. PubMed ID: 29155069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.